Oncolines – Case Studies in Translational Medicine
Oncolines®2023-08-22T16:25:52+02:00
Target identification via Oncolines® profiling and ResidenceTimer™
Target identification via Oncolines® profiling and [...]
Oncolines®2023-05-29T14:24:33+02:00
Combination matrix to determine Bliss independence synergy scores
Combination matrix to determine Bliss independence synergy scores
Oncolines®2023-05-29T15:59:34+02:00
Case study – Synergistic interaction of olaparib and cisplatin
Synergistic interaction of olaparib and cisplatin [...]
Oncolines®2023-05-29T15:58:13+02:00
Case study – Pharmacological models to assess the role of tryptophan-metabolizing enzymes in cancer
Pharmacological models to assess the role [...]
janneke2023-05-29T15:56:23+02:00
Case study – Gene expression profiling to understand and combat drug resistance
RNA sequencing provides insight into the [...]
Oncolines®2023-05-29T16:00:20+02:00
Case study – TTK patient stratification marker
Patient stratification markers for TTK inhibitors [...]
Oncolines®2023-05-29T16:01:07+02:00
Case study – MEK inhibitor
New response biomarkers for the MEK [...]
Oncolines®2023-05-29T16:01:43+02:00
Case study – Kadcyla®
Comparison of the antibody-drug conjugate Kadcyla® [...]
Oncolines®2023-05-29T16:03:02+02:00
Case study – CDK4/6
Biomarker discovery for CDK4/6 inhibitors Analysis [...]
yvonne2023-05-29T15:56:55+02:00
Case Study – 3D spheroid drug sensitivity
Increased drug sensitivity towards sotorasib in [...]